SCHEMBL845376

SCHEMBL845376

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3NCc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)Cc1cccnc1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
VNN1 O95497 1/20 0.44
TRPV1 Q8NER1 2/20 0.42
ITGB1 P05556 7/20 0.40
ITGA4 P13612 7/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PAX8 Q06710 1/20 0.39
USP2 O75604 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HCRTR1 O43613 2/20 0.39
HCRTR2 O43614 2/20 0.39
ACE P12821 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845682 0.89 ALDH1A1 (0.54) ALDH1A1MEN1KMT2AUSP2KDM4E
SCHEMBL845015 0.87 ALDH1A1 (0.42) ALDH1A1VNN1ITGB1ITGA4MEN1
SCHEMBL845027 0.86 ALDH1A1 (0.48) ALDH1A1TRPV1ITGB1ITGA4MEN1
SCHEMBL845189 0.86 ALDH1A1 (0.49) ALDH1A1ITGB1ITGA4MEN1KMT2A
SCHEMBL845375 0.85 MAPK1 (0.46) ALDH1A1MEN1KMT2AKDM4E
SCHEMBL845712 0.85 HRH3 (0.50) ALDH1A1ITGB1ITGA4PAX8KDM4E
SCHEMBL845371 0.85 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AUSP2KDM4E
SCHEMBL845191 0.84 HRH3 (0.52) ALDH1A1VNN1TRPV1PAX8KDM4E
SCHEMBL845534 0.83 HRH3 (0.43) ALDH1A1VNN1TRPV1ITGB1ITGA4
SCHEMBL845401 0.83 ALDH1A1 (0.45) ALDH1A1VNN1TRPV1ITGB1ITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed